Found: 11
Select item for more details and to access through your institution.
Interleukin-6 and C-reactive protein levels after 3 years of treatment with darunavir/ritonavir monotherapy or darunavir/ritonavir + two nucleoside reverse transcriptase inhibitors in the MONET trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 7, p. 1804, doi. 10.1093/jac/dks102
- By:
- Publication type:
- Article
Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials.
- Published in:
- AIDS Research & Treatment, 2014, p. 1, doi. 10.1155/2014/636584
- By:
- Publication type:
- Article
The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19525
- By:
- Publication type:
- Article
Transcript analysis of 1003 novel yeast genes using high-throughput northern hybridizations.
- Published in:
- EMBO Journal, 2001, v. 20, n. 12, p. 3177, doi. 10.1093/emboj/20.12.3177
- By:
- Publication type:
- Article
No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0109718
- By:
- Publication type:
- Article
Transcript analysis of 250 novel yeast genes from chromosome XIV.
- Published in:
- Yeast, 1999, v. 15, n. 4, p. 329, doi. 10.1002/(SICI)1097-0061(19990315)15:4<329::AID-YEA360>3.0.CO;2-C
- By:
- Publication type:
- Article
Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 5, p. 563, doi. 10.1002/jcph.245
- By:
- Publication type:
- Article
Predictors of long-term HIV RNA suppression on darunavir/ritonavir monotherapy in the MONET trial.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV.
- Published in:
- Southern African Journal of HIV Medicine, 2019, v. 20, n. 1, p. 1, doi. 10.4102/sajhivmed.v20i1.949
- By:
- Publication type:
- Article
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 4, p. 1090
- By:
- Publication type:
- Article